Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for tetrahydrocannabinol (compound)


PubChem
Name: Tetrahydrocannabinol
PubChem Compound ID: 11012622
Description: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.
Molecular formula: C21H30O2
Molecular weight: 319.493 g/mol
DrugBank
Identification
Name: Tetrahydrocannabinol
Name (isomeric): DB00470
Drug Type: small molecule
Description: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.
Brand: delta-9-tetrahydrocannabinol, Δ9-tetrahydrocannabinol, Dronabinol, Dea No. 7369, Marinol, Dea No. 7370, Δ9-THC, Abbott 40566, Dronabinolum [Latin], delta-9-THC, Dronabinol [Usan:Inn], Deltanyne
Category: Analgesics, Non-Narcotic, Psychotropic Drugs, Hallucinogens, Antiemetics, Analgesics
CAS number: 1972-08-3
Pharmacology
Indication: For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments
Pharmacology: Marinol may has complex effects on the central nervous system (CNS), including cannabinoid receptors. Dronabinol may inhibit endorphins in the emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action.
Mechanism of Action:
The mechanism of action of marinol is not completely understood. It is thought that cannabinoid receptors in neural tissues may mediate the effects of dronabinol and other cannabinoids. Animal studies with other cannabinoids suggest that marinol's antiemetic effects may be due to inhibition of the vomiting control mechanism in the medulla oblongata...
show more »
Absorption: 90 - 95%
Protein binding: 97%
Biotransformation: Hepatic
Route of elimination: Dronabinol and its biotransformation products are excreted in both feces and urine.
Half Life: Alpha phase: approximately 4 hours; Beta phase: 25-36 hours
Clearance: 0.2 L/kg-hr
Affected organisms: Humans and other mammals
Interactions
Food interaction:
Avoid alcohol.
Take without regard to meals.
Drug interaction:
TrimethobenzamideAnticholinergics, such as Trimethobenzamide, may increase the tachycardic effect of cannabinoids such as Marinol. Close monitoring of cardiovascular effects is recommended.
TrospiumAnticholinergics, such as Trospium, may increase the tachycardic effect of cannabinoids such as Marinol. Close monitoring of cardiovascular effects is recommended.

Targets


Enzymes


Transporters